Stay updated on FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial
Sign up to get notified when there's something new on the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page.

Latest updates to the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1 on the page. No visible changes to study content or page behavior.SummaryDifference0.0%

- Check16 days agoChange DetectedPublications section now states that entries are automatically filled from PubMed and may not all pertain to the study, adding clarity on content provenance. The revision tag has changed from v3.2.0 to v3.3.1 and the previous wording was removed.SummaryDifference0.1%

- Check23 days agoChange DetectedThe government funding lapse notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check38 days agoChange DetectedNo additions or deletions were detected. The study details and related sections appear unchanged.SummaryDifference0.4%

- Check67 days agoChange DetectedUpdate: version revision changed from v3.0.2 to v3.2.0.SummaryDifference0.0%

- Check68 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.0%

Stay in the know with updates to FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page.